Mersana Therapeutics Return on Investment 2016-2019 | MRSN

Current and historical return on investment (ROI) values for Mersana Therapeutics (MRSN) over the last 10 years.
Mersana Therapeutics ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2019-03-31 $-0.03B $0.13B -101.59%
2018-12-31 $-0.07B inf%
2018-09-30 $-0.06B inf%
2018-06-30 $-0.05B inf%
2018-03-31 $-0.04B inf%
2017-12-31 $-0.04B inf%
2017-06-30 $-0.02B inf%
2017-03-31 $-0.02B inf%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.192B $0.011B
Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.282B 12.13
Gilead Sciences (GILD) United States $82.754B 10.05
Celgene (CELG) United States $63.100B 10.69
Biogen (BIIB) United States $45.076B 8.56
Vertex Pharmaceuticals (VRTX) United States $44.586B 53.90
Illumina (ILMN) United States $43.847B 50.81
CSL (CSLLY) Australia $35.477B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.403B 15.23
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.429B 15.52
Incyte (INCY) United States $17.522B 71.05
Exact Sciences (EXAS) United States $14.987B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.612B 0.00
SINO PHARMACEUT (SBMFF) China $14.357B 0.00
Seattle Genetics (SGEN) United States $12.302B 0.00
Genmab (GNMSF) Denmark $11.046B 56.15
Sarepta Therapeutics (SRPT) United States $10.732B 0.00
Array BioPharma (ARRY) United States $10.407B 0.00
Galapagos (GLPG) Belgium $9.614B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.283B 49.21
QIAGEN (QGEN) Netherlands $9.002B 29.57
Guardant Health (GH) United States $8.169B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.138B 0.00
Bio-Techne Corp (TECH) United States $7.906B 53.94
Bluebird Bio (BLUE) United States $7.710B 0.00
Exelixis (EXEL) United States $6.485B 16.53
BeiGene (BGNE) Cayman Islands $6.041B 0.00
Amarin (AMRN) Ireland $5.976B 0.00
Ascendis Pharma (ASND) Denmark $5.009B 0.00
Blueprint Medicines (BPMC) United States $4.876B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.789B 0.00
Moderna (MRNA) United States $4.623B 0.00
Horizon Pharma Public (HZNP) Ireland $4.434B 11.42
Repligen (RGEN) United States $4.169B 103.86
Mirati Therapeutics (MRTX) United States $3.808B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.744B 0.00
Spark Therapeutics (ONCE) United States $3.703B 0.00
China Biologic Products (CBPO) China $3.670B 23.31
Ultragenyx Pharmaceutical (RARE) United States $3.627B 0.00
Alkermes (ALKS) Ireland $3.582B 0.00
MorphoSys AG (MOR) Germany $3.523B 0.00
Arena Pharmaceuticals (ARNA) United States $3.088B 6.27
Immunomedics (IMMU) United States $2.967B 0.00
Amicus Therapeutics (FOLD) United States $2.936B 0.00
Reata Pharmaceuticals (RETA) United States $2.712B 0.00
Medicines (MDCO) United States $2.698B 0.00
UniQure (QURE) Netherlands $2.681B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.613B 0.00
MyoKardia (MYOK) United States $2.499B 0.00
Halozyme Therapeutics (HALO) United States $2.395B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $2.338B 0.00
NeoGenomics (NEO) United States $2.216B 145.06
Acceleron Pharma (XLRN) United States $2.213B 0.00
Ligand Pharmaceuticals (LGND) United States $2.198B 18.20
Emergent Biosolutions (EBS) United States $2.194B 19.06
Zai Lab (ZLAB) China $2.111B 0.00
Genomic Health (GHDX) United States $2.087B 44.32
Akcea Therapeutics (AKCA) United States $2.081B 0.00
Myriad Genetics (MYGN) United States $2.034B 20.23
Intercept Pharmaceuticals (ICPT) United States $1.997B 0.00
Denali Therapeutics (DNLI) United States $1.946B 0.00
REGENXBIO (RGNX) United States $1.853B 0.00
Insmed (INSM) United States $1.685B 0.00
RA PHARMCTL INC (RARX) United States $1.522B 0.00
Cambrex (CBM) United States $1.495B 18.90
AnaptysBio (ANAB) United States $1.483B 0.00
Fate Therapeutics (FATE) United States $1.465B 0.00
Sangamo Therapeutics (SGMO) United States $1.366B 0.00
Innoviva (INVA) United States $1.333B 3.69
Athenex (ATNX) United States $1.310B 0.00
Alector (ALEC) United States $1.302B 0.00
Editas Medicine (EDIT) United States $1.220B 0.00
Epizyme (EPZM) United States $1.191B 0.00
Coherus BioSciences (CHRS) United States $1.183B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.159B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.057B 0.00
Twist Bioscience (TWST) United States $1.031B 0.00
Cara Therapeutics (CARA) United States $1.028B 0.00
Codexis (CDXS) United States $1.005B 0.00
ANI Pharmaceuticals (ANIP) United States $0.979B 17.36
Momenta Pharmaceuticals (MNTA) United States $0.961B 0.00
Zymeworks (ZYME) Canada $0.952B 0.00
Principia Biopharma (PRNB) United States $0.928B 0.00
Adverum Biotechnologies (ADVM) United States $0.904B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.903B 0.00
Retrophin (RTRX) United States $0.881B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.860B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Vericel (VCEL) United States $0.811B 0.00
Intellia Therapeutics (NTLA) United States $0.806B 0.00
Arvinas (ARVN) United States $0.800B 0.00
WAVE Life Sciences (WVE) Singapore $0.775B 0.00
Precision BioSciences (DTIL) United States $0.706B 0.00
Zealand Pharma (ZEAL) Denmark $0.702B 8.20
Zealand Pharma (ZLDPF) Denmark $0.683B 0.00
Cytokineticsorporated (CYTK) United States $0.671B 0.00
Intra-Cellular Therapies (ITCI) United States $0.661B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.657B 31.02
Cellectis S.A (CLLS) France $0.648B 0.00
Heska (HSKA) United States $0.617B 63.16
DBV Technologies S.A (DBVT) France $0.595B 0.00
Anika Therapeutics (ANIK) United States $0.582B 19.88
Autolus Therapeutics (AUTL) United Kingdom $0.581B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.579B 0.00
Stemline Therapeutics (STML) United States $0.577B 0.00
Clovis Oncology (CLVS) United States $0.575B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.568B 0.00
Revance Therapeutics (RVNC) United States $0.560B 0.00
MiMedx (MDXG) United States $0.524B 0.00
Pharming Group (PHGUF) Netherlands $0.521B 0.00
Mesoblast (MESO) Australia $0.497B 0.00
CytomX Therapeutics (CTMX) United States $0.492B 0.00
PHARMA MAR SA (PHMMF) Spain $0.454B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.437B 0.00
UROGEN PHARMA (URGN) United States $0.426B 0.00
Prothena (PRTA) Ireland $0.393B 0.00
Puma Biotechnology (PBYI) United States $0.387B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.384B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.382B 0.00
AC Immune SA (ACIU) Switzerland $0.380B 24.43
Arcus Biosciences (RCUS) United States $0.377B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Bellus Health (BLUSF) Canada $0.370B 0.00
PDL BioPharma (PDLI) United States $0.367B 8.77
Gritstone Oncology (GRTS) United States $0.364B 0.00
Starpharma Holdings (SPHRY) Australia $0.360B 0.00
Avid Bioservices (CDMO) United States $0.351B 0.00
Albireo Pharma (ALBO) United States $0.345B 0.00
Merus (MRUS) Netherlands $0.342B 0.00
BioDelivery Sciences (BDSI) United States $0.341B 0.00
Biofrontera AG (BFRA) Germany $0.341B 0.00
Scholar Rock Holding (SRRK) United States $0.334B 0.00
Kadmon Holdings (KDMN) United States $0.331B 0.00
Agenus (AGEN) United States $0.328B 0.00
Prometic Life Sciences (PFSCD) Canada $0.322B 0.00
Syros Pharmaceuticals (SYRS) United States $0.321B 0.00
Acorda Therapeutics (ACOR) United States $0.317B 5.58
Sorrento Therapeutics (SRNE) United States $0.315B 0.00
Theratechnologies (THERF) Canada $0.310B 0.00
Protagonist Therapeutics (PTGX) United States $0.303B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.297B 0.00
Senesco Technologies (ELOX) United States $0.293B 0.00
Inovio Pharmaceuticals (INO) United States $0.276B 0.00
Cellular Biomedicine (CBMG) United States $0.274B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.256B 0.00
Sutro Biopharma (STRO) United States $0.255B 0.00
ChromaDex (CDXC) United States $0.248B 0.00
Kindred Biosciences (KIN) United States $0.247B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.246B 0.00
PHASEBIO PHARMA (PHAS) United States $0.240B 0.00
Kamada (KMDA) Israel $0.239B 9.27
Pieris Pharmaceuticals (PIRS) United States $0.228B 0.00
Dynavax Technologies (DVAX) United States $0.218B 0.00
Geron (GERN) United States $0.216B 0.00
CorMedix Inc (CRMD) United States $0.215B 0.00
ADMA Biologics Inc (ADMA) United States $0.215B 0.00
Athersys (ATHX) United States $0.214B 0.00
Palatin Technologies (PTN) United States $0.210B 0.00
Cel-Sci (CVM) United States $0.209B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.202B 0.00
Five Prime Therapeutics (FPRX) United States $0.198B 0.00
MannKind (MNKD) United States $0.197B 0.00
Cerecor (CERC) United States $0.194B 0.00
Pfenex (PFNX) United States $0.187B 0.00
POXEL SA FRANCE (PXXLF) $0.184B 0.00
OSMOTICA PHARM (OSMT) United States $0.184B 0.00
Affimed (AFMD) Germany $0.183B 0.00
Abeona Therapeutics (ABEO) United States $0.183B 0.00
Spero Therapeutics (SPRO) United States $0.182B 0.00
Enzo Biochem (ENZ) United States $0.175B 0.00
XOMA (XOMA) United States $0.171B 0.00
Compugen (CGEN) Israel $0.171B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Synlogic (SYBX) United States $0.164B 0.00
BioTime (BTX) United States $0.163B 10.90
Arsanis (XFOR) United States $0.162B 0.00
Nicox SA (NICXF) France $0.159B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.155B 0.00
Alcobra (ARCT) United States $0.152B 0.00
Cue Biopharma (CUE) United States $0.148B 0.00
Liquidia Technologies (LQDA) United States $0.145B 0.00
Strongbridge Biopharma (SBBP) United States $0.145B 8.34
OvaScience (MLND) United States $0.144B 0.00
Adocia (ADOCY) France $0.140B 0.00
Celyad SA (CYAD) Belgium $0.140B 0.00
Windtree Therapeutics (WINT) United States $0.138B 0.00
Dyadic (DYAI) United States $0.136B 0.00
Northwest Biotherapeutics (NWBO) United States $0.133B 0.00
TOCAGEN INC (TOCA) United States $0.131B 0.00
Seres Therapeutics (MCRB) United States $0.124B 0.00
NantKwest (NK) United States $0.123B 0.00
Aptinyx (APTX) United States $0.120B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.111B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.109B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.108B 0.00
Novavax (NVAX) United States $0.108B 0.00
Arbutus Biopharma (ABUS) Canada $0.107B 0.00
Aduro Biotech (ADRO) United States $0.106B 0.00
Verastem (VSTM) United States $0.103B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
Menlo Therapeutics (MNLO) United States $0.102B 0.00
Checkpoint Therapeutics (CKPT) United States $0.101B 0.00
Catalyst Biosciences (CBIO) United States $0.100B 0.00
SESEN BIO, INC (SESN) United States $0.094B 0.00
Trevena (TRVN) United States $0.088B 0.00
Pluristem Therapeutics (PSTI) Israel $0.085B 0.00
Fortress Biotech (FBIO) United States $0.085B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.085B 0.00
Curis (CRIS) United States $0.083B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.082B 0.00
VBI Vaccines (VBIV) United States $0.080B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.079B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.077B 0.00
Unum Therapeutics (UMRX) United States $0.075B 0.00
Selecta Biosciences (SELB) United States $0.073B 0.00
Idera Pharmaceuticals (IDRA) United States $0.071B 0.00
Applied Genetic Technologies (AGTC) United States $0.071B 39.10
AquaBounty Technologies (AQB) United States $0.071B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.071B 0.00
VTv Therapeutics (VTVT) United States $0.070B 0.00
Orgenesis (ORGS) United States $0.068B 0.00
Oncobiologics (OTLK) United States $0.064B 0.00
Signal Genetics (MGEN) United States $0.063B 0.00
NewLink Genetics (NLNK) United States $0.062B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Antibe Therapeutics (ATBPF) Canada $0.059B 0.00
ARAVIVE, INC (ARAV) United States $0.059B 0.00
Protalix BioTherapeutics (PLX) Israel $0.059B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.057B 0.00
AIT Therapeutics (XAIR) United States $0.056B 0.00
Invo BioScience (IVOB) United States $0.053B 0.00
Vaccinex (VCNX) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Ophthotech (ISEE) United States $0.047B 0.00
Proteostasis Therapeutics (PTI) United States $0.045B 0.00
Entera Bio (ENTX) Israel $0.043B 0.29
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
AEterna Zentaris (AEZS) United States $0.042B 0.00
Clearside Biomedical (CLSD) United States $0.041B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.041B 0.00
Apricus Biosciences (SEEL) United States $0.040B 0.00
Aptevo Therapeutics (APVO) United States $0.040B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Celsion (CLSN) United States $0.036B 0.00
VIVUS (VVUS) United States $0.035B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.032B 0.00
Caladrius Biosciences (CLBS) United States $0.031B 0.00
Celldex Therapeutics (CLDX) United States $0.030B 0.00
Bionano Genomics (BNGO) United States $0.029B 0.00
Aytu Bioscience (AYTU) United States $0.028B 0.00
VistaGen Therapeutics (VTGN) United States $0.024B 0.00
Soligenix (SNGX) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
Vical (VICL) United States $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
IBio (IBIO) United States $0.014B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Genetic Technologies (GENE) Australia $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
AmpliPhi Biosciences (ARMP) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Hemispherx BioPharma (HEB) United States $0.006B 0.00
Neuralstem (CUR) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
Stellar Biotechnologies (EDSA) United States $0.005B 0.00
BioPharmX (BPMX) United States $0.004B 0.00